Table 1.
Expression of the v-ErbA target genes in T2ECs during the differentiation process or following a T3, RA or T3 and RA treatment.
| Genes | Differentiation | T3 | RA | T3+RA |
| Sca2 | - - | 0 | + + | + + |
| LOC129881 | - - | 0 | + | 0 |
| eIF2B2 | - | 0 | + | + |
| RNF13 | - | 0 | 0 | 0 |
| TGF-β1 | - - | - | 0 | - |
| β-Actin | - - | 0 | 0 | 0 |
| TPT1 | + | 0 | 0 | 0 |
| RPS3 | 0 | 0 | 0 | 0 |
| NAP1L1 | - | 0 | 0 | 0 |
| RPS9 | + | 0 | 0 | 0 |
| RPS3a | + | 0 | 0 | 0 |
| eEF1α1 | 0* | 0 | 0 | 0 |
| RPL13 | 0 | 0 | 0 | 0 |
| MGC83969 | 0 | 0 | 0 | 0 |
| HMG17 | - | 0 | 0 | 0 |
Expression levels of v-ErbA target genes, quantified by real-time PCR, were classified into three groups as follows: (++) strong activation, (+) moderate activation, (0) no variation, (-) repression and (--) strong repression by the different treatments. The table is the synthesis of the results obtained. For actual values and conditions used – see supplementary data. We used, as the reference gene for this experiment, eEF1α1* in agreement with Damiola et al., 2004.